US Stock MarketDetailed Quotes

Neurocrine Biosciences (NBIX)

Watchlist
  • 131.780
  • +0.110+0.08%
Close May 1 16:00 ET
  • 131.780
  • 0.0000.00%
Post 16:10 ET
13.25BMarket Cap28.22P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neurocrine Biosciences (NBIX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.46%782.7M
60.16%388.4M
43.99%227.5M
57.89%102M
-50.27%64.8M
52.71%595.4M
96.36%242.5M
-25.47%158M
-64.03%64.6M
204.07%130.3M
Net income from continuing operations
40.23%478.6M
49.08%153.7M
61.40%209.5M
65.38%107.5M
-81.80%7.9M
36.68%341.3M
-30.20%103.1M
56.20%129.8M
-31.94%65M
156.66%43.4M
Depreciation and amortization
11.07%30.1M
5.63%7.5M
18.46%7.7M
0.00%7.3M
22.58%7.6M
27.23%27.1M
24.56%7.1M
18.18%6.5M
43.14%7.3M
24.00%6.2M
Deferred tax
234.36%165.4M
253.99%48.2M
582.23%168.3M
9.44%-37.4M
12.18%-13.7M
-117.11%-123.1M
-251.94%-31.3M
-730.95%-34.9M
0.48%-41.3M
50.63%-15.6M
Other non cash items
-87.94%14.8M
290.00%3.9M
80.79%-3.9M
-79.82%11.5M
-96.12%3.3M
763.24%122.7M
116.95%1M
-65.04%-20.3M
28,600.00%57M
85,100.00%85M
Change In working capital
-570.83%-128.8M
26.41%119.2M
-4,309.09%-185.2M
54.69%-39.1M
25.00%-23.7M
-168.09%-19.2M
275.61%94.3M
-90.43%4.4M
-192.40%-86.3M
45.04%-31.6M
-Change in receivables
-428.89%-210.5M
1,820.00%38.4M
-925.58%-132.3M
-352.84%-79.7M
-226.55%-36.9M
55.43%-39.8M
109.35%2M
57.57%-12.9M
-519.05%-17.6M
72.90%-11.3M
-Change in inventory
19.90%-15.3M
70.69%-3.4M
-272.73%-12.3M
139.62%2.1M
-254.55%-1.7M
-453.70%-19.1M
-1,188.89%-11.6M
-213.79%-3.3M
-431.25%-5.3M
-38.89%1.1M
-Change in payables and accrued expense
269.12%160.2M
-1.03%76.5M
26.24%55.8M
126.05%15.5M
166.67%12.4M
-11.43%43.4M
178.64%77.3M
-64.47%44.2M
-467.28%-59.5M
-377.61%-18.6M
-Change in other working capital
-1,608.11%-63.2M
-71.05%7.7M
-308.47%-96.4M
689.74%23M
189.29%2.5M
-105.86%-3.7M
-60.24%26.6M
53.63%-23.6M
-105.46%-3.9M
88.48%-2.8M
Cash from discontinued investing activities
Operating cash flow
31.46%782.7M
60.16%388.4M
43.99%227.5M
57.89%102M
-50.27%64.8M
52.71%595.4M
96.36%242.5M
-25.47%158M
-64.03%64.6M
204.07%130.3M
Investing cash flow
Cash flow from continuing investing activities
-108.52%-264.4M
22.55%-52.9M
-896.36%-196.7M
-2.84%-29M
125.82%14.2M
72.85%-126.8M
66.15%-68.3M
125.39%24.7M
77.60%-28.2M
-30.64%-55M
Capital expenditure reported
10.99%-34M
132.88%2.4M
-62.96%-13.2M
-7.76%-12.5M
4.46%-10.7M
-34.98%-38.2M
-35.19%-7.3M
-6.58%-8.1M
-70.59%-11.6M
-31.76%-11.2M
Net business purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
-160.05%-230.4M
9.34%-55.3M
-659.45%-183.5M
0.60%-16.5M
156.85%24.9M
79.81%-88.6M
68.94%-61M
136.57%32.8M
86.06%-16.6M
-30.36%-43.8M
Cash from discontinued investing activities
Investing cash flow
-108.52%-264.4M
22.55%-52.9M
-896.36%-196.7M
-2.84%-29M
125.82%14.2M
72.85%-126.8M
66.15%-68.3M
125.39%24.7M
77.60%-28.2M
-30.64%-55M
Financing cash flow
Cash flow from continuing financing activities
92.13%-38.3M
112.86%37.3M
72.73%45.6M
98.87%-3.3M
-268.67%-117.9M
-845.33%-486.7M
-919.21%-290M
40.43%26.4M
-10,203.45%-293M
752.44%69.9M
Net issuance payments of debt
--0
--0
--0
----
----
---308.8M
--0
--0
----
----
Net common stock issuance
44.10%-167.7M
--0
--0
---17.7M
---150M
---300M
---300M
--0
--0
--0
Proceeds from stock option exercised by employees
5.98%129.4M
273.00%37.3M
72.73%45.6M
-8.86%14.4M
-54.08%32.1M
86.98%122.1M
-71.75%10M
40.43%26.4M
444.83%15.8M
752.44%69.9M
Cash from discontinued financing activities
Financing cash flow
92.13%-38.3M
112.86%37.3M
72.73%45.6M
98.87%-3.3M
-268.67%-117.9M
-845.33%-486.7M
-919.21%-290M
40.43%26.4M
-10,203.45%-293M
752.44%69.9M
Net cash flow
Beginning cash position
-6.99%241M
-2.49%348.2M
84.16%272M
-50.01%202.1M
-6.99%241M
-4.29%259.1M
18.36%357.1M
-12.19%147.7M
262.28%404.3M
-4.29%259.1M
Current changes in cash
2,751.93%480M
421.93%372.8M
-63.46%76.4M
127.16%69.7M
-126.79%-38.9M
-52.10%-18.1M
-169.93%-115.8M
56.63%209.1M
-553.36%-256.6M
191.26%145.2M
Effect of exchange rate changes
--0
--0
-166.67%-200K
----
----
--0
-200.00%-300K
--300K
----
----
End cash Position
199.17%721M
199.17%721M
-2.49%348.2M
84.16%272M
-50.01%202.1M
-6.99%241M
-6.99%241M
18.36%357.1M
-12.19%147.7M
262.28%404.3M
Free cash flow
34.37%748.7M
66.16%390.8M
42.96%214.3M
68.87%89.5M
-54.58%54.1M
54.09%557.2M
99.15%235.2M
-26.66%149.9M
-69.33%53M
189.08%119.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.46%782.7M60.16%388.4M43.99%227.5M57.89%102M-50.27%64.8M52.71%595.4M96.36%242.5M-25.47%158M-64.03%64.6M204.07%130.3M
Net income from continuing operations 40.23%478.6M49.08%153.7M61.40%209.5M65.38%107.5M-81.80%7.9M36.68%341.3M-30.20%103.1M56.20%129.8M-31.94%65M156.66%43.4M
Depreciation and amortization 11.07%30.1M5.63%7.5M18.46%7.7M0.00%7.3M22.58%7.6M27.23%27.1M24.56%7.1M18.18%6.5M43.14%7.3M24.00%6.2M
Deferred tax 234.36%165.4M253.99%48.2M582.23%168.3M9.44%-37.4M12.18%-13.7M-117.11%-123.1M-251.94%-31.3M-730.95%-34.9M0.48%-41.3M50.63%-15.6M
Other non cash items -87.94%14.8M290.00%3.9M80.79%-3.9M-79.82%11.5M-96.12%3.3M763.24%122.7M116.95%1M-65.04%-20.3M28,600.00%57M85,100.00%85M
Change In working capital -570.83%-128.8M26.41%119.2M-4,309.09%-185.2M54.69%-39.1M25.00%-23.7M-168.09%-19.2M275.61%94.3M-90.43%4.4M-192.40%-86.3M45.04%-31.6M
-Change in receivables -428.89%-210.5M1,820.00%38.4M-925.58%-132.3M-352.84%-79.7M-226.55%-36.9M55.43%-39.8M109.35%2M57.57%-12.9M-519.05%-17.6M72.90%-11.3M
-Change in inventory 19.90%-15.3M70.69%-3.4M-272.73%-12.3M139.62%2.1M-254.55%-1.7M-453.70%-19.1M-1,188.89%-11.6M-213.79%-3.3M-431.25%-5.3M-38.89%1.1M
-Change in payables and accrued expense 269.12%160.2M-1.03%76.5M26.24%55.8M126.05%15.5M166.67%12.4M-11.43%43.4M178.64%77.3M-64.47%44.2M-467.28%-59.5M-377.61%-18.6M
-Change in other working capital -1,608.11%-63.2M-71.05%7.7M-308.47%-96.4M689.74%23M189.29%2.5M-105.86%-3.7M-60.24%26.6M53.63%-23.6M-105.46%-3.9M88.48%-2.8M
Cash from discontinued investing activities
Operating cash flow 31.46%782.7M60.16%388.4M43.99%227.5M57.89%102M-50.27%64.8M52.71%595.4M96.36%242.5M-25.47%158M-64.03%64.6M204.07%130.3M
Investing cash flow
Cash flow from continuing investing activities -108.52%-264.4M22.55%-52.9M-896.36%-196.7M-2.84%-29M125.82%14.2M72.85%-126.8M66.15%-68.3M125.39%24.7M77.60%-28.2M-30.64%-55M
Capital expenditure reported 10.99%-34M132.88%2.4M-62.96%-13.2M-7.76%-12.5M4.46%-10.7M-34.98%-38.2M-35.19%-7.3M-6.58%-8.1M-70.59%-11.6M-31.76%-11.2M
Net business purchase and sale ----------------------0----------------
Net investment purchase and sale -160.05%-230.4M9.34%-55.3M-659.45%-183.5M0.60%-16.5M156.85%24.9M79.81%-88.6M68.94%-61M136.57%32.8M86.06%-16.6M-30.36%-43.8M
Cash from discontinued investing activities
Investing cash flow -108.52%-264.4M22.55%-52.9M-896.36%-196.7M-2.84%-29M125.82%14.2M72.85%-126.8M66.15%-68.3M125.39%24.7M77.60%-28.2M-30.64%-55M
Financing cash flow
Cash flow from continuing financing activities 92.13%-38.3M112.86%37.3M72.73%45.6M98.87%-3.3M-268.67%-117.9M-845.33%-486.7M-919.21%-290M40.43%26.4M-10,203.45%-293M752.44%69.9M
Net issuance payments of debt --0--0--0-----------308.8M--0--0--------
Net common stock issuance 44.10%-167.7M--0--0---17.7M---150M---300M---300M--0--0--0
Proceeds from stock option exercised by employees 5.98%129.4M273.00%37.3M72.73%45.6M-8.86%14.4M-54.08%32.1M86.98%122.1M-71.75%10M40.43%26.4M444.83%15.8M752.44%69.9M
Cash from discontinued financing activities
Financing cash flow 92.13%-38.3M112.86%37.3M72.73%45.6M98.87%-3.3M-268.67%-117.9M-845.33%-486.7M-919.21%-290M40.43%26.4M-10,203.45%-293M752.44%69.9M
Net cash flow
Beginning cash position -6.99%241M-2.49%348.2M84.16%272M-50.01%202.1M-6.99%241M-4.29%259.1M18.36%357.1M-12.19%147.7M262.28%404.3M-4.29%259.1M
Current changes in cash 2,751.93%480M421.93%372.8M-63.46%76.4M127.16%69.7M-126.79%-38.9M-52.10%-18.1M-169.93%-115.8M56.63%209.1M-553.36%-256.6M191.26%145.2M
Effect of exchange rate changes --0--0-166.67%-200K----------0-200.00%-300K--300K--------
End cash Position 199.17%721M199.17%721M-2.49%348.2M84.16%272M-50.01%202.1M-6.99%241M-6.99%241M18.36%357.1M-12.19%147.7M262.28%404.3M
Free cash flow 34.37%748.7M66.16%390.8M42.96%214.3M68.87%89.5M-54.58%54.1M54.09%557.2M99.15%235.2M-26.66%149.9M-69.33%53M189.08%119.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -